214 related articles for article (PubMed ID: 24721622)
1. Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells.
Yu Y; Zhang X; Hong S; Zhang M; Cai Q; Jiang W; Xu C
J Ovarian Res; 2014; 7():39. PubMed ID: 24721622
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells.
Yu Y; Zhang M; Zhang X; Cai Q; Zhu Z; Jiang W; Xu C
J Exp Clin Cancer Res; 2014 Sep; 33(1):85. PubMed ID: 25261977
[TBL] [Abstract][Full Text] [Related]
3. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
Aponte M; Jiang W; Lakkis M; Li MJ; Edwards D; Albitar L; Vitonis A; Mok SC; Cramer DW; Ye B
Cancer Res; 2008 Jul; 68(14):5839-48. PubMed ID: 18632638
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells.
Yu Y; Zhang M; Zhang X; Cai Q; Hong S; Jiang W; Xu C
J Hematol Oncol; 2014 May; 7():39. PubMed ID: 24886678
[TBL] [Abstract][Full Text] [Related]
5. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway.
Marques SA; Dy LC; Southall MD; Yi Q; Smietana E; Kapur R; Marques M; Travers JB; Spandau DF
J Pharmacol Exp Ther; 2002 Mar; 300(3):1026-35. PubMed ID: 11861812
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation.
Snider AJ; Zhang Z; Xie Y; Meier KE
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C163-70. PubMed ID: 19864325
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation.
Zhou W; Ibe BO; Raj JU
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2773-81. PubMed ID: 17322418
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
[TBL] [Abstract][Full Text] [Related]
9. PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway.
Kim YH; Lee SJ; Seo KW; Bae JU; Park SY; Kim EK; Bae SS; Kim JH; Kim CD
J Lipid Res; 2013 Oct; 54(10):2678-86. PubMed ID: 23911909
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production.
Ahamed J; Ali H
J Biol Chem; 2002 Jun; 277(25):22685-91. PubMed ID: 11934880
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
Melnikova VO; Mourad-Zeidan AA; Lev DC; Bar-Eli M
J Biol Chem; 2006 Feb; 281(5):2911-22. PubMed ID: 16306050
[TBL] [Abstract][Full Text] [Related]
12. The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.
Deuster E; Hysenaj I; Kahaly M; Schmoeckel E; Mayr D; Beyer S; Kolben T; Hester A; Kraus F; Chelariu-Raicu A; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
Cells; 2021 Sep; 10(9):. PubMed ID: 34571986
[TBL] [Abstract][Full Text] [Related]
13. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF.
Shindou H; Ishii S; Uozumi N; Shimizu T
Biochem Biophys Res Commun; 2000 May; 271(3):812-7. PubMed ID: 10814544
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic phospholipase A2 induction and prostaglandin E2 release by interleukin-1β via the myeloid differentiation factor 88-dependent pathway and cooperation of p300, Akt, and NF-κB activity in human rheumatoid arthritis synovial fibroblasts.
Chi PL; Luo SF; Hsieh HL; Lee IT; Hsiao LD; Chen YL; Yang CM
Arthritis Rheum; 2011 Oct; 63(10):2905-17. PubMed ID: 21702012
[TBL] [Abstract][Full Text] [Related]
15. Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.
Zhang L; Wang D; Jiang W; Edwards D; Qiu W; Barroilhet LM; Rho JH; Jin L; Seethappan V; Vitonis A; Wang J; Mok SC; Crum C; Cramer DW; Ye B
Reprod Biol Endocrinol; 2010 Jun; 8():74. PubMed ID: 20576130
[TBL] [Abstract][Full Text] [Related]
16. Role of the platelet-activating factor and its receptor in the proliferative regulation of bovine ovarian granulosa cells.
Viergutz T; Löhrke B
Cell Prolif; 2007 Dec; 40(6):949-60. PubMed ID: 18021181
[TBL] [Abstract][Full Text] [Related]
17. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
Lukashova V; Chen Z; Duhé RJ; Rola-Pleszczynski M; Stanková J
J Immunol; 2003 Oct; 171(7):3794-800. PubMed ID: 14500680
[TBL] [Abstract][Full Text] [Related]
18. Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.
Sahu RP; Kozman AA; Yao Y; DaSilva SC; Rezania S; Martel KC; Warren SJ; Travers JB; Konger RL
Carcinogenesis; 2012 Mar; 33(3):694-701. PubMed ID: 22223848
[TBL] [Abstract][Full Text] [Related]
19. G-protein-independent activation of Tyk2 by the platelet-activating factor receptor.
Lukashova V; Asselin C; Krolewski JJ; Rola-Pleszczynski M; Stanková J
J Biol Chem; 2001 Jun; 276(26):24113-21. PubMed ID: 11309383
[TBL] [Abstract][Full Text] [Related]
20. Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway.
Hamel-Côté G; Gendron D; Rola-Pleszczynski M; Stankova J
PLoS One; 2017; 12(7):e0180336. PubMed ID: 28686728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
